At present, Adaptimmune Therapeutics Plc ADR (ADAP) has a stock price of $0.43. In the previous session, the stock saw a rise, peaking at $0.50 after an opening price of $0.50. The day’s lowest price was $0.42, and it closed at $0.48.
Adaptimmune Therapeutics Plc ADR ‘s stock market performance has been somewhat erratic. The company’s stock reached a 1-year high price of $2.54 on 11/22/22, while the lowest value for the same period was recorded at $0.44 on 11/20/23.
52-week price history of ADAP Stock
A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Adaptimmune Therapeutics Plc ADR’s current trading price is -83.11% away from its 52-week high, while its distance from the 52-week low is -2.50%. The stock’s price range during this period has spanned from $0.44 to $2.54. In the Healthcare sector, the Adaptimmune Therapeutics Plc ADR’s shares surpassed a trading volume of approximately 1.16 million for the day, which was noticeably higher compared to the average daily volume of 9.0.41 million over the past three months.
Market Capitalization and Financial Performance: An In-Depth Look
Adaptimmune Therapeutics Plc ADR (ADAP) has experienced a quarterly decline of -45.45% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 97.35M and boasts a workforce of 407 employees.
Making Sense of Trading Volume and Moving Average Data
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.7517, with a change in price of -0.5070. Similarly, Adaptimmune Therapeutics Plc ADR recorded 498,918 in trading volume during the last 100 days, posting a change of -54.17%.
Examining ADAP’s Debt-to-Equity Ratio: What You Need to Know
The debt-to-equity (D/E) ratio is a crucial measure that sheds light on a company’s financial health and market standing. It is determined by dividing a company’s overall liabilities by its shareholders’ equity, showing the extent of a company’s debt usage in financing its assets compared to the shareholders’ equity. At the time of writing, the total D/E ratio for ADAP stands at 0.29. Similarly, the long-term debt-to-equity ratio is also 0.23.
ADAP Stock Stochastic Average
Today’s raw stochastic average for Adaptimmune Therapeutics Plc ADR over the last 50 days is 2.09%.This indicates a decrease from the raw stochastic average of the past 20 days, which was 3.91%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 15.79% and 20.83%, respectively.
ADAP Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. Year to date metric has recorded a loss of -70.62%.However, over the last six months, we can see a stronger performance of -66.48%. Over the last 30 days, the price of ADAP has leaped by -24.07%. And in the last five days, it has fallen by -9.23%.
